Samsung Medical: On February 25, net short selling was 49,300 shares, with a total net sell-off of 66,600 shares over the past 3 days.

NightAirdropper · 2026-02-26T21:29:15+00:00

On February 25th, Samsung Medical's net financing sell-off was 30.561 million yuan, with a financing balance of 301 million yuan. In terms of securities lending, there was a net sell-off of 49,300 shares, with a securities lending balance of 207,000 shares. The total of margin financing and securities lending balances was 306 million yuan, a decrease of 8.7% compared to yesterday.

NightAirdropper

2026-02-26 21:29:15

Abstract generation in progress

Securities Star News: On February 25th, Samsung Medical (601567) had a margin buy-in of 35.245 million yuan, a margin repayment of 65.806 million yuan, resulting in a net margin sell of 30.561 million yuan. The margin balance was 301 million yuan.

In terms of securities lending, on that day, 50,300 shares were sold short, 1,000 shares were repaid, resulting in a net short sale of 49,300 shares. The remaining securities lending balance was 207,000 shares, with a net sell of 66,600 shares over the past three trading days.

The total margin and securities lending balance was 306 million yuan, down 8.7% from yesterday.

Quick Fact

Margin Trading and Securities Lending: Margin trading means a securities company lends money to investors to buy stocks. When the loan is due, the principal and interest are repaid together. Securities lending can be understood as investors borrowing stocks to sell; they return the stocks and pay interest when due. Generally, investors buy stocks on margin if they are optimistic about the stock price, and sell short if they are bearish.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes